At Embla, we help employers deliver better weight loss outcomes with less medication, fewer side effects, and more sustainable results.Talk to our team tolearn how we help self-funded employers launch structured, high-impact GLP-1 benefits
When promotional content outpaces evidence-based guidance, people are left to navigate complex medical decisions without the balanced information they deserve
The key to proper use of nutritional supplements is in the name: "supplement." Supplements are designed to complement a healthy diet and lifestyle
This evidence will help determine the extent of your injuries and their impact on your life
MedBound Hub GLP-1 Drugs: Fighting Diabetes and Weight Gain General Madhumathi.N.Lambi December 25, 2025, 1:49pm 1 GLP-1 Drugs: Fighting Diabetes and Weight In recent years, GLP-1 receptor agonists have transformed the treatment landscape for type 2 diabetes and obesity, blurring the line between metabolic disease management and weight-loss therapy
GLP-1 receptor agonists such as semaglutide (marketed as Ozempic and Wegovy) and dual GIP/GLP-1 agonist tirzepatide (Mounjaro) have become increasingly popular for weight loss in both women and men